Your browser doesn't support javascript.
loading
Benefits of early application of pelvic circumferential compression device to reduce bleeding in pelvic fractures.
Rungsinaporn, Visit; Akkarawanit, Pawin; Kongmalai, Pinkawas.
Afiliação
  • Rungsinaporn V; Department of Orthopaedics, Faculty of Medicine, Srinakharinwirot University, 62 Moo 7, Rangsit-Nakhon Nayok Road, Ongkharak, Nakhon Nayok, 26120, Thailand.
  • Akkarawanit P; Department of Orthopaedics, Faculty of Medicine, Srinakharinwirot University, 62 Moo 7, Rangsit-Nakhon Nayok Road, Ongkharak, Nakhon Nayok, 26120, Thailand.
  • Kongmalai P; Department of Orthopaedics, Faculty of Medicine, Srinakharinwirot University, 62 Moo 7, Rangsit-Nakhon Nayok Road, Ongkharak, Nakhon Nayok, 26120, Thailand. pinkawass@hotmail.com.
BMC Musculoskelet Disord ; 23(1): 203, 2022 Mar 03.
Article em En | MEDLINE | ID: mdl-35241032
ABSTRACT

BACKGROUND:

To study of efficacy of early pelvic circumferential compression device using in patients with suspected pelvic trauma, compared with conventional stepwise approach.

METHODS:

Traumatic injury and at least one of the following criteria are required for inclusion loss of consciousness or a Glasgow coma score (GCS) of less than 13; systolic blood pressure less than 90 mmHg; falling from more than 6 m; injury to several important organs; and a positive pelvic compression test. Patients who satisfied the inclusion criteria for the experimental group were given an early application of a commercial pelvic sling beginning in July 2019. The control group consisted of cases who got the device after clinical or radiological confirmation of a pelvic fracture in the previous year. Gender, age, mechanism of injury, GCS, hospital stay, amount of packed red blood cell transfusion, hematocrit in emergency room, and hematocrit 24 h after application of pelvic binder were all assessed and compared.

RESULTS:

The study had a total of 30 participants, with 15 in each group. The number of packed red blood cell transfusions in the early pelvic binder group (0.80 ± 1.42) is considerably lower than in the control group (2.4 ± 2.32) (P = 0.008), although the hematocrit change is not statistically different between the groups (2.1 VS 0.7) (P = 0.191). The time it took to install a pelvic binder was considerably shorter in the early pelvic binder group (16.40 ± 5.45) than in the control group (40.40 ± 13.64) (P = 0.001). There were no problems associated to soft tissue and skin necrosis in either group of patients.

CONCLUSIONS:

The use of the PCCD for 24 h prior to clinical and radiographic confirmation has significantly reduced the rate of packed red blood cell transfusion in any pelvic fracture patient without device-related complications. TRIAL REGISTRATION The study was entered into the Thai Clinical Trials Registry ( TCTR20210809007 ).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ossos Pélvicos / Fraturas Ósseas Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Musculoskelet Disord Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ossos Pélvicos / Fraturas Ósseas Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Musculoskelet Disord Ano de publicação: 2022 Tipo de documento: Article